At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
NXL Nexalin Technology, Inc.
Market Closed 11-15 16:00:00 EST
4.22
+0.12
+2.93%
盘后4.19
-0.03-0.75%
19:59 EST
High4.30
Low3.80
Vol989.00K
Open4.10
D1 Closing4.10
Amplitude12.09%
Mkt Cap54.28M
Tradable Cap43.87M
Total Shares12.86M
T/O4.05M
T/O Rate9.51%
Tradable Shares10.40M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer's disease, and dementia. The company is based in Houston, Texas.